NEW ORLEANS – The director of the John Ochsner Heart and Vascular Institute (JOHVI) Christopher J. White, MD, FACC, FAHA, FSCAI, FESC has been recognized by the American College of Cardiology (ACC) as a 2019 Master of the ACC Award for outstanding contributions to the field of cardiovascular medicine. Details were shared in a press release.
Awarded annually, the Master of the ACC Award recognizes and honors Fellows of the ACC who have consistently contributed to the goals and programs of ACC and have provided leadership in important ACC activities. To qualify, the honoree must have been members of the ACC for at least 15 years and have served with distinction and provided leadership on various ACC programs and committees. Recipients are nominated by their peers and then selected by the ACC awards committee. Dr. White was recognized with this honor during the ACC’s 68th Annual Scientific Session this March in New Orleans.
With more than four decades of experience, Dr. White has practiced medicine in San Francisco, CA; Washington, D.C.; Glasgow, Scotland and New Orleans, LA. In addition to his role with JOHVI, Dr. White currently serves as the Medical Director of Value Based Care and System Chairman for cardiovascular disease for Ochsner Health System and is Professor and Chairman of Medicine and Cardiology for the University of Queensland Ochsner Clinical School.
Dr. White is a past president of the Society of Cardiovascular Angiography and Interventions (SCAI) and a past steering committee chairman for the National Cardiovascular Database Registry’s (NCDR) carotid and peripheral revascularization efforts. He serves as editor for Progress in Cardiovascular Disease, associate editor for JACC Interventions and previously served as editor-in-chief for Catheterization and Cardiovascular Interventions.
Dr. White graduated Alpha Omega Alpha (AOA) Honor Medical Society from Case Western Reserve Medical School in Cleveland, Ohio and completed his residency in internal medicine and fellowship in cardiology at Letterman Army Medical Center (LAMC) in San Francisco, CA.
JOHVI has been a regional and national leader in cardiology and cardiac surgery for decades. In 2017, JOHVI performed its 500th LVAD and 950th heart transplant. JOHVI is home to more than 50 cardiologists and surgeons who work closely with each patient to develop a customized healthcare plan that is both targeted and effective. Ochsner also participates in more than 100 clinical trials for the goal of advancing knowledge of the mechanisms, treatments and diagnoses of cardiovascular disease.
